The Role of Chlamydia trachomatis Polymorphic Membrane Proteins in Inflammation and Sequelae among Women with Pelvic Inflammatory Disease
Table 2
Frequency of baseline inflammatory markers and reproductive sequelae by PmpA antibody expression.
Inflammation and sequelae
PmpA
No
Yes
value
Inflammation
aElevated temperature (>100.4°F)
0 (0.0)
1 (25.0)
0.1111
aElevated WBC count (>10,000 mm3)
8 (23.5)
2 (40.0)
0.2856
Erythrocyte sedimentation rate (>15 mm/hr)
11 (31.4)
2 (40.0)
0.7019
aC-reactive protein (>5 mg/dL)
6 (46.2)
2 (66.7)
0.5218
Bilateral adnexal tenderness
28 (80.0)
4 (80.0)
1.000
aMucopurulent cervicitis
20 (66.7)
3 (60.0)
0.7712
Upper genital tract infection
15 (46.7)
3 (75.0)
0.2494
aEndometritis
17 (60.7)
4 (100.0)
0.1664
Reproductive sequelae
Infertility
5 (14.3)
0 (0.0)
0.3663
bLive birth
20 (80.0)
0 (0.0)
0.0053
Pregnancy
30 (85.7)
1 (40.0)
0.0422
bChronic pelvic pain
13 (38.2)
0 (0.0)
0.1142
bRecurrent PID
6 (17.7)
0 (0.0)
0.4122
aWBC data was available for 39 patients, CRP data was available for 16 patients, mucopurulent cervicitis data was available for 35 patients, UGTI data was available for 36 patients, and endometritis data was available for 32 patients; blive birth data was available for 29 patients; chronic pelvic pain and recurrent PID data were available for 39 patients.
